Developer docs
API playgroundTry for free, no card

Search company profiles

Myralis

Full company profile

uuid000ff9s

Namestring
Myralis
Legal namestring
Myralis
Websiteurl
myralis.com.br
Company typeenum
Private
Founded yearstring
-
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersValinhos, Brazil
HQ citystring
Valinhos
HQ countrystring
Brazil
HQ regionstring
Latin America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
dietary supplements, consumer health products, OTC medications, vitamin supplements, pharmaceutical manufacturing
Industry1 code
PRIMARYHLAIADAN
Vitamins, Minerals & Supplements (VMS)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
NAICS code2 codes
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
  • Drugs and Druggists' Sundries Merchant Wholesalers4242
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Consumer Health Products
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical and Health Supplements Sales
TypeOne Time License
Description

Myralis generates revenue through the sale of over-the-counter pharmaceutical products, dietary supplements, and medical devices. Products are distributed through pharmacies, drugstores, and online retail channels across Brazil. The company produces over 50 million products annually across more than 30 brands.

myralis.com.br:443
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1DPrev
Description

Vitamin D (colecalciferol) dietary supplement that aids in bone and teeth formation, muscle functioning, and immune system functioning.

myralis.com.br:443
+5 more records
Core offering1 text field

Myralis manufactures and supplies a portfolio of more than 30 health-focused brands including food supplements (vitamin D, B12, cranberry extract), pediatric supplements, OTC medications (osmotic laxatives), and medical devices (nasal wash). Products are distributed through major pharmacy chains, independent drugstores, and online retail channels across Brazil, supported by a field sales team visiting 14,000+ sales points and engaging 86,000+ doctors. The company produces more than 50 million units annually.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Over 50 million products produced annually
Product overview1 text field

Myralis is a pharmaceutical company offering a portfolio of more than 30 health and wellness brands across supplements, medical devices, and medications. The product portfolio includes vitamin supplements (DPrev, MecoBe), a nasal wash device (Nasoar), a constipation treatment (PEG-Lax), pediatric supplements (Puravit), and a urinary health supplement (Urocran). The company distributes through pharmacies, drugstores, and online retailers across Brazil, and operates a loyalty program (Sua Saúde Myralis) and a medical education platform (Educa+ Myralis).

Product and service6 records
1DPrev
CategoryDietary Supplement (Vitamin D)
Description

Dietary supplement based on vitamin D (colecalciferol) that aids bone and teeth formation, muscle functioning, and immune system support. Indicated for maintaining adequate vitamin D levels in the blood. Marketed to adult consumers seeking vitamin D supplementation.

2MecoBe
CategoryDietary Supplement (Vitamin B12)
Description

Sublingual mecobalamin (vitamin B12) supplement providing rapid absorption directly into the bloodstream without relying on gastrointestinal absorption. Indicated for B12 supplementation, including in people with gastric or intestinal absorption impairments.

3Nasoar
CategoryMedical Device (Nasal Care)
Description

High-volume nasal wash medical device that mechanically acts on the nasal mucosa, fluidifying and removing mucus to provide nasal decongestion and relief. Targeted at consumers with nasal congestion, allergies, or sinus discomfort.

4PEG-Lax
CategoryOTC Laxative Medication
Description

Non-irritating osmotic laxative indicated for occasional constipation. Promotes stool softening and increased evacuation frequency by retaining water within the intestine. Targeted at adult consumers managing occasional digestive irregularity.

5Puravit
CategoryPediatric Dietary Supplement
Description

Children's dietary supplement line developed to support healthy growth and development, providing important micronutrients for childhood health and wellness. Targeted at parents and caregivers of young children seeking nutritional supplementation.

6Urocran
CategoryDietary Supplement (Urinary Tract Health)
Description

Food supplement containing Pacran, an exclusive cranberry (Vaccinium macrocarpon Aiton) extract with innovative extraction methods ensuring standardization, safety, and quality. Targeted at consumers seeking urinary tract health support.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of Brazil's largest pharmaceutical manufacturers with a broad OTC and prescription portfolio sold through pharmacy chains nationwide. Highly comparable to Myralis given overlapping Brazil-focused distribution model, multi-brand OTC strategy, and similar target customers.

2Eurofarma
TypeDirect peer
Description

Major Brazilian pharmaceutical manufacturer with significant OTC and supplement offerings sold through drugstore chains. Comparable to Myralis in scale, geographic focus, and channel strategy within Brazil.

TypeDirect peer
Description

Brazilian pharmaceutical company with broad OTC and supplement brands (e.g., Viter C, Lavitan) sold heavily through pharmacy chains. Highly comparable to Myralis in portfolio approach, price-point positioning, and retail-channel dominance.

4Bayer Consumer Health
TypeBroad incumbent
Description

Global consumer health division with established OTC/vitamin brands (e.g., Redoxon, Elevit, Berocca) sold in Brazilian pharmacies. Comparable to Myralis in supplement category overlap but operates as a multinational incumbent with far greater scale and R&D.

TypeDirect peer
Description

Brazilian pharma company with a strong presence in prescription and OTC categories including supplements. Comparable to Myralis in scale, Brazilian focus, and reliance on doctor-channel and pharmacy distribution.

TypeBroad incumbent
Description

Global consumer health company with OTC supplement brands (Centrum, Caltrate, Maltofer) sold through Brazilian pharmacies. Overlaps with Myralis in vitamin/mineral supplement categories but competes as a global incumbent with superior marketing budget and brand recognition.

TypeDirect peer
Description

Brazilian pharma company with a strong OTC, supplements, and consumer health portfolio distributed through retail pharmacies. Directly comparable to Myralis in product mix, brand portfolio breadth, and Brazilian pharmacy-channel GTM.

TypeEmerging player
Description

Brazilian manufacturer of botanical and herbal supplements including cranberry-based products. Comparable to Myralis in the herbal/botanical supplement category (Urocran-style cranberry positioning) but smaller scale and narrower category focus.

TypeBroad incumbent
Description

Brazil's largest consumer health/pharma company with marquee OTC brands across multiple categories. Larger and broader than Myralis but operates in the same Brazilian pharmacy channel with overlapping supplement and OTC segments.

TypeBroad incumbent
Description

Global pharma with a significant OTC and supplement portfolio (e.g., Enterogermina, Pharmaton) widely distributed through Brazilian pharmacies. Comparable in product categories but operates at much greater scale as a multinational incumbent.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Myralis

Consumer Health Productsmyralis.com.br

Myralis firmographics

Firmographics
Name
Myralis
Legal name
Myralis
Website
https://myralis.com.br
Company type
Private
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Myralis industry classification

Industry
Product category
Consumer Health Products
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (4242)
SIC
Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYHLAIADAN
Vitamins, Minerals & Supplements (VMS)
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

  • Dietary supplements
  • Consumer health products
  • OTC medications
  • Vitamin supplements
  • Pharmaceutical manufacturing

Where Myralis is headquartered

Location

Headquarters

HQ city
Valinhos
HQ country
Brazil
HQ region
Latin America

Offices1 record

Markets served

Myralis business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

  1. Pharmaceutical and Health Supplements Sales: Myralis generates revenue through the sale of over-the-counter pharmaceutical products, dietary supplements, and medical devices. Products are distributed through pharmacies, drugstores, and online retail channels across Brazil. The company produces over 50 million products annually across more than 30 brands.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Myralis product offering

Product offering

Core offering

Myralis manufactures and supplies a portfolio of more than 30 health-focused brands including food supplements (vitamin D, B12, cranberry extract), pediatric supplements, OTC medications (osmotic laxatives), and medical devices (nasal wash). Products are distributed through major pharmacy chains, independent drugstores, and online retail channels across Brazil, supported by a field sales team visiting 14,000+ sales points and engaging 86,000+ doctors. The company produces more than 50 million units annually.

Product overview

Myralis is a pharmaceutical company offering a portfolio of more than 30 health and wellness brands across supplements, medical devices, and medications. The product portfolio includes vitamin supplements (DPrev, MecoBe), a nasal wash device (Nasoar), a constipation treatment (PEG-Lax), pediatric supplements (Puravit), and a urinary health supplement (Urocran). The company distributes through pharmacies, drugstores, and online retailers across Brazil, and operates a loyalty program (Sua Saúde Myralis) and a medical education platform (Educa+ Myralis).

Differentiator

Problem solved

Functional benefit

Brands

  • DPrev: Vitamin D (colecalciferol) dietary supplement that aids in bone and teeth formation, muscle functioning, and immune system functioning.
  • Mecobe
  • Nasoar
  • Peg-Lax
  • Puravit
  • Urocran

Products and services

  • DPrev Dietary supplement based on vitamin D (colecalciferol) that aids bone and teeth formation, muscle functioning, and immune system support. Indicated for maintaining adequate vitamin D levels in the blood. Marketed to adult consumers seeking vitamin D supplementation.
  • MecoBe Sublingual mecobalamin (vitamin B12) supplement providing rapid absorption directly into the bloodstream without relying on gastrointestinal absorption. Indicated for B12 supplementation, including in people with gastric or intestinal absorption impairments.
  • Nasoar High-volume nasal wash medical device that mechanically acts on the nasal mucosa, fluidifying and removing mucus to provide nasal decongestion and relief. Targeted at consumers with nasal congestion, allergies, or sinus discomfort.
  • PEG-Lax Non-irritating osmotic laxative indicated for occasional constipation. Promotes stool softening and increased evacuation frequency by retaining water within the intestine. Targeted at adult consumers managing occasional digestive irregularity.
  • Puravit Children's dietary supplement line developed to support healthy growth and development, providing important micronutrients for childhood health and wellness. Targeted at parents and caregivers of young children seeking nutritional supplementation.
  • Urocran Food supplement containing Pacran, an exclusive cranberry (Vaccinium macrocarpon Aiton) extract with innovative extraction methods ensuring standardization, safety, and quality. Targeted at consumers seeking urinary tract health support.

Quantifiable outcome

  • Over 50 million products produced annually

Companies that use Myralis

Customer profile

Segments3 records

Ideal customer profiles3 records

Myralis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Myralis partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Myralis competitors and assessment

Company assessment

Direct peers

  • EMS Pharma: One of Brazil's largest pharmaceutical manufacturers with a broad OTC and prescription portfolio sold through pharmacy chains nationwide. Highly comparable to Myralis given overlapping Brazil-focused distribution model, multi-brand OTC strategy, and similar target customers.
  • Eurofarma: Major Brazilian pharmaceutical manufacturer with significant OTC and supplement offerings sold through drugstore chains. Comparable to Myralis in scale, geographic focus, and channel strategy within Brazil.
  • Cimed: Brazilian pharmaceutical company with broad OTC and supplement brands (e.g., Viter C, Lavitan) sold heavily through pharmacy chains. Highly comparable to Myralis in portfolio approach, price-point positioning, and retail-channel dominance.
  • Biolab Farmacêutica: Brazilian pharma company with a strong presence in prescription and OTC categories including supplements. Comparable to Myralis in scale, Brazilian focus, and reliance on doctor-channel and pharmacy distribution.
  • Aché Laboratórios: Brazilian pharma company with a strong OTC, supplements, and consumer health portfolio distributed through retail pharmacies. Directly comparable to Myralis in product mix, brand portfolio breadth, and Brazilian pharmacy-channel GTM.

Broad incumbents

  • Bayer Consumer Health: Global consumer health division with established OTC/vitamin brands (e.g., Redoxon, Elevit, Berocca) sold in Brazilian pharmacies. Comparable to Myralis in supplement category overlap but operates as a multinational incumbent with far greater scale and R&D.
  • GSK Consumer Healthcare: Global consumer health company with OTC supplement brands (Centrum, Caltrate, Maltofer) sold through Brazilian pharmacies. Overlaps with Myralis in vitamin/mineral supplement categories but competes as a global incumbent with superior marketing budget and brand recognition.
  • Hypera (formerly Hypermarcas): Brazil's largest consumer health/pharma company with marquee OTC brands across multiple categories. Larger and broader than Myralis but operates in the same Brazilian pharmacy channel with overlapping supplement and OTC segments.
  • Sanofi Consumer Healthcare: Global pharma with a significant OTC and supplement portfolio (e.g., Enterogermina, Pharmaton) widely distributed through Brazilian pharmacies. Comparable in product categories but operates at much greater scale as a multinational incumbent.

Emerging players

  • HERBAMED: Brazilian manufacturer of botanical and herbal supplements including cranberry-based products. Comparable to Myralis in the herbal/botanical supplement category (Urocran-style cranberry positioning) but smaller scale and narrower category focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Myralis social profiles

Digital presence

Myralis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Myralis leadership team

Management profile

Number of profiles

Myralis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Myralis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Myralis

What does Myralis do?

Myralis manufactures and supplies a portfolio of more than 30 health-focused brands including food supplements (vitamin D, B12, cranberry extract), pediatric supplements, OTC medications (osmotic laxatives), and medical devices (nasal wash). Products are distributed through major pharmacy chains, independent drugstores, and online retail channels across Brazil, supported by a field sales team visiting 14,000+ sales points and engaging 86,000+ doctors. The company produces more than 50 million units annually.

Is Myralis a public or private company?

Myralis is a private company. It is classified as unknown and is currently operating.

When was Myralis founded?

Myralis was founded in -1. It employs 1,001 to 5,000 people.

Where is Myralis based?

Myralis is headquartered in Valinhos, Brazil, in the Latin America region.

How does Myralis make money?

One revenue line is on record: pharmaceutical and Health Supplements Sales.

Who are Myralis's main competitors?

Direct peers on record are EMS Pharma, Eurofarma, Cimed, Biolab Farmacêutica and Aché Laboratórios. Broad incumbents are Bayer Consumer Health, GSK Consumer Healthcare, Hypera (formerly Hypermarcas) and Sanofi Consumer Healthcare. HERBAMED is listed as an emerging player.

Does Myralis have an API?

No public API is recorded for Myralis.

What industry is Myralis in?

Myralis's product category is Consumer Health Products. Its primary akta.pro industry code is HLAIADAN, Vitamins, Minerals & Supplements (VMS). Its NAICS code is 42421 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals